Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway-Reference-Cited by-同舟云学术

Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway

Published:2022-05 Issue:3 Volume:27 Page:100680
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Shen Ling,Gu Peng^ORCID,Qiu Chen,Ding Wen-tao,Zhang Lei,Cao Wan-yue,Li Zu-yin,Yan Bin,Sun Xing

Funder

Shanghai Jiao Tong University

Natural Science Foundation of Shanghai

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference37 articles.

1. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

2. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis;Tang;Abdom Radiol (NY),2018

3. EASL clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018

4. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

5. EMT in cancer;Brabletz;Nat Rev Cancer,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of LPCAT1 as a key biomarker for Crohn's disease based on bioinformatics and machine learnings and experimental verification;Gene;2024-08

2. Phospholipid Acyltransferases: Characterization and Involvement of the Enzymes in Metabolic and Cancer Diseases;Cancers;2024-05-31

3. Profiling of serum metabolome of breast cancer: multi-cancer features discriminate between healthy women and patients with breast cancer;Frontiers in Oncology;2024-04-04

4. Molecular cloning, tissue expression pattern, responses to different fatty acids and potential functions of lysophosphatidylcholine acyltransferase 1 (LPCAT1) in large yellow croaker (Larimichthys crocea);Gene;2024-02

5. miR-557 suppresses hepatocellular carcinoma cell proliferation and migration via downregulating CBX4;BIOCELL;2024